Global Bioengineering Technology Market Report 2025-2034

Market Overview and Sustainable Development Goals (SDGs) Alignment

The Global Bioengineering Technology Market is projected to grow from USD 294.5 billion in 2025 to USD 835.4 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 12.3%. This growth is driven by significant advancements in gene-editing technologies such as CRISPR-Cas9, bioprinting, and the integration of artificial intelligence (AI), which collectively support personalized medicine and sustainable practices.

Bioengineering technology plays a critical role in advancing several United Nations Sustainable Development Goals (SDGs), including:

• SDG 3: Good Health and Well-being – Through innovations in personalized medicine and advanced therapeutic solutions.
• SDG 2: Zero Hunger – By enhancing sustainable agricultural practices to improve food security.
• SDG 9: Industry, Innovation, and Infrastructure – Via the development of cutting-edge bioengineering technologies and industrial bio-based processes.
• SDG 12: Responsible Consumption and Production – Through the promotion of bio-based materials and environmentally friendly production methods.
• SDG 13: Climate Action – By reducing dependence on fossil fuels through biofuels and sustainable bioengineering applications.

Market Segmentation

1. By Product
2. By Technology
3. By Application
4. By Geography
   • North America (USA, Canada, Mexico)
   • Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
   • Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC)
   • The Middle East and Africa (Middle East, Africa)
   • South and Central America (Brazil, Argentina, Rest of SCA)

Key Market Drivers Supporting SDGs

• Growing demand for personalized medicine and advanced therapeutic solutions, contributing to SDG 3: Good Health and Well-being.
• Increasing emphasis on sustainable agricultural practices and bio-based industrial processes, aligning with SDG 2: Zero Hunger and SDG 12: Responsible Consumption and Production.
• Strong investments from governments, research institutions, and private companies in bioengineering research and development, fostering innovation under SDG 9: Industry, Innovation, and Infrastructure.

Market Trends Enhancing Sustainable Development

• Rapid advancements in gene-editing technologies, particularly CRISPR, driving innovation in healthcare and agriculture, supporting SDG 3 and SDG 2.
• Integration of bioengineering with AI and data analytics accelerates research and product development, enhancing efficiency and innovation consistent with SDG 9.
• Expansion of bio-based materials and biofuels addresses environmental sustainability and reduces reliance on fossil resources, contributing to SDG 12 and SDG 13: Climate Action.

Challenges Impacting Sustainable Progress

• High costs and technical complexities in developing and scaling bioengineering technologies.
• Regulatory and ethical considerations, especially concerning genetic modifications and synthetic biology.
• Limited infrastructure and expertise in certain regions, which may slow the adoption of advanced bioengineering applications, affecting equitable progress towards SDGs.

Regional Market Insights

North America and Europe currently lead the bioengineering technology market, supported by robust research funding, established biotechnology industries, and favorable regulatory frameworks. Asia-Pacific is emerging rapidly due to increased investments in biotechnology research, expanding healthcare infrastructure, and rising demand for agricultural and industrial bioengineering solutions. These regional dynamics are crucial for achieving global sustainable development targets.

Leading Companies in the Bioengineering Technology Sector

• Pfizer Inc.
• Johnson & Johnson
• Roche Holding AG
• Novartis AG
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific
• Abbott Laboratories
• AstraZeneca plc
• Medtronic plc
• Gilead Sciences Inc.
• Amgen Inc.
• Novo Nordisk A/S
• Moderna Inc.
• Becton Dickinson (BD)
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Inc.
• Agilent Technologies
• Lonza Group Ltd.
• Intuitive Surgical
• Illumina Inc.
• Bio-Rad Laboratories
• Ginkgo Bioworks
• Verve Therapeutics Inc.
• CRISPR Therapeutics

Report Details

Additional Insights Provided in the Report

• Global market size and growth projections (CAGR) from 2024 to 2034.
• Impact of geopolitical, economic, and trade policy changes on demand and supply chains.
• Market size, share, and outlook across five regions and 27 countries.
• Market size, CAGR, and market share of key products, applications, and end-user verticals.
• Short and long-term market trends, drivers, restraints, and opportunities.
• Porter’s Five Forces analysis and supply chain evaluation.
• Trade and price analysis, along with value chain assessment.
• Profiles of five leading companies, including strategies, financials, and products.
• Latest market news and developments.

Conclusion

The bioengineering technology market is poised for significant expansion, driven by innovations that align closely with multiple Sustainable Development Goals. By fostering advancements in healthcare, agriculture, environmental sustainability, and industrial processes, bioengineering technologies contribute to global efforts in achieving sustainable development and improving quality of life worldwide.

For further information, please visit the full report at https://www.researchandmarkets.com/r/ko965u.

1. Sustainable Development Goals (SDGs) Addressed or Connected

1. SDG 3: Good Health and Well-being
   • The article discusses advancements in personalized medicine, gene-editing technologies such as CRISPR-Cas9, and regenerative medicine, all contributing to improved healthcare outcomes.
2. SDG 2: Zero Hunger
   • Emphasis on sustainable agricultural practices and bioengineering solutions to improve agricultural productivity addresses food security.
3. SDG 9: Industry, Innovation and Infrastructure
   • Development and integration of advanced bioengineering technologies, AI, and data analytics promote innovation and industrial growth.
4. SDG 12: Responsible Consumption and Production
   • Expansion of bio-based materials and biofuels supports sustainable production and reduces dependence on fossil resources.
5. SDG 13: Climate Action
   • Bioengineering technologies contribute to environmental sustainability and addressing climate change challenges.

2. Specific Targets Under Identified SDGs

1. SDG 3: Good Health and Well-being
   • Target 3.4: Reduce premature mortality from non-communicable diseases through prevention and treatment.
   • Target 3.b: Support the research and development of vaccines and medicines for communicable and non-communicable diseases.
2. SDG 2: Zero Hunger
   • Target 2.3: Double the agricultural productivity and incomes of small-scale food producers through sustainable practices.
   • Target 2.4: Ensure sustainable food production systems and implement resilient agricultural practices.
3. SDG 9: Industry, Innovation and Infrastructure
   • Target 9.5: Enhance scientific research and upgrade technological capabilities of industrial sectors.
   • Target 9.b: Support domestic technology development and research in developing countries.
4. SDG 12: Responsible Consumption and Production
   • Target 12.2: Achieve sustainable management and efficient use of natural resources.
   • Target 12.5: Substantially reduce waste generation through prevention, reduction, recycling, and reuse.
5. SDG 13: Climate Action
   • Target 13.1: Strengthen resilience and adaptive capacity to climate-related hazards and natural disasters.

3. Indicators Mentioned or Implied to Measure Progress

1. Market Size and Growth
   • Indicator: Market value in USD (e.g., USD 294.5 billion in 2025, projected USD 835.4 billion by 2034).
   • Indicator: Compound Annual Growth Rate (CAGR) of 12.3% indicating expansion of bioengineering technologies.
2. Technological Advancements
   • Indicator: Adoption rate and development of gene-editing technologies like CRISPR-Cas9.
   • Indicator: Integration of AI and data analytics in bioengineering R&D.
3. Regional Development
   • Indicator: Investment levels and infrastructure growth in regions such as North America, Europe, and Asia-Pacific.
4. Sustainable Practices
   • Indicator: Expansion and usage rates of bio-based materials and biofuels.
   • Indicator: Implementation of sustainable agricultural practices.
5. Healthcare Outcomes
   • Implied Indicator: Availability and effectiveness of personalized medicine and advanced therapeutic solutions.

4. Table of SDGs, Targets, and Indicators

Source: uk.finance.yahoo.com